Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600PRNewsWire • 07/20/26
Krystal Biotech (KRYS) Soars 3.4%: Is Further Upside Left in the Stock?Zacks Investment Research • 06/29/26
Entertainment Stocks Madison Square Garden, Sphere Rally To New HighsInvestors Business Daily • 06/26/26
These 3 Stocks Have Crushed the Market This Year. Here's Why There Is More Upside AheadThe Motley Fool • 06/18/26
Is the Options Market Predicting a Spike in Krystal Biotech Stock?Zacks Investment Research • 06/05/26
Here's Why Krystal Biotech, Inc. (KRYS) is a Strong Momentum StockZacks Investment Research • 05/26/26
Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference CallGlobeNewsWire • 05/21/26
Krystal Biotech Announces United Kingdom MHRA Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis BullosaGlobeNewsWire • 05/18/26
Krystal Biotech, Inc. (KRYS) Presents at Bank of America Global Healthcare Conference 2026 TranscriptSeeking Alpha • 05/13/26
Krystal Biotech Q1 Earnings & Sales Beat Estimates, Pipeline in FocusZacks Investment Research • 05/05/26
Krystal Biotech, Inc. (KRYS) Tops Q1 Earnings and Revenue EstimatesZacks Investment Research • 05/04/26
Krystal Biotech, Inc. (KRYS) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 04/27/26
Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026GlobeNewsWire • 04/21/26